Literature DB >> 11514004

Cardiac avoidance in breast radiotherapy: a comparison of simple shielding techniques with intensity-modulated radiotherapy.

D Landau1, E J Adams, S Webb, G Ross.   

Abstract

BACKGROUND AND
PURPOSE: Adjuvant breast radiotherapy (RT) is now part of the routine care of patients with early breast cancer. However, analysis of the Early Breast Cancer Trialists' Collaborative suggests that patients with the lowest risk of dying of breast cancer are at significant risk of cardiac mortality due to longer relapse-free survival. Patients with a significant amount of heart in the high-dose volume have been shown to be at risk of fatal cardiac events. This study was designed to assess whether conformal planning or intensity-modulated radiotherapy (IMRT) techniques allow reduced cardiac irradiation whilst maintaining full target coverage.
MATERIAL AND METHODS: Ten patients with early breast cancer were available for computed tomography (CT) planning. Each had at least 1 cm maximum heart depth within the posterior border of conventional tangents. For each patient, plans were generated and compared using dose volume histograms for planning target volume (PTV) and organs at risk. The plans included conventional tangents with and without shielding. The shielding was designed to either completely spare the heart or to shield as much heart as possible without compromising PTV coverage. IMRT plans were also prepared using two- and four-field tangential and six-field arc-like beam arrangements.
RESULTS: PTV homogeneity was better for the tangential IMRT techniques. For all patients, cardiac irradiation was reduced by the addition of partial cardiac shielding to conventional tangents, without compromise of PTV coverage. The two- and four-field IMRT techniques also reduced heart doses. The average percentage volume of heart receiving >60% of the prescription dose was 4.4% (range 1.0-7.1%) for conventional tangents, 1.5% (0.2-3.9%) for partial shielding, 2.3% (0.5-4.6%) for the two-field IMRT technique and 2.2% (0.4-5.6%) for the four-field IMRT technique. For patients with larger maximum heart depths the four-field IMRT plan achieved greater heart sparing than the partial shielding, although irradiation of the contralateral breast was increased. Full cardiac shielding resulted in the most complete heart sparing but with compromise of the PTV coverage; the mean volume receiving less than 95% of the prescription dose was 4% (range 1.5-8.7%).
CONCLUSION: All patients undergoing adjuvant tangential breast RT in whom the heart is seen to be in the high-dose volume should be considered for the addition of cardiac-sparing lead blocks. Three-dimensional CT planning and alternative beam arrangements with IMRT optimization enables more complete cardiac sparing without compromise of PTV coverage in certain patients.

Entities:  

Mesh:

Year:  2001        PMID: 11514004     DOI: 10.1016/s0167-8140(01)00374-7

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  20 in total

1.  Helical tomotherapy in patients with breast cancer and complex treatment volumes.

Authors:  Ricardo Cendales; Luis Schiappacasse; Franco Schnitman; Graciela García; Hugo Marsiglia
Journal:  Clin Transl Oncol       Date:  2011-04       Impact factor: 3.405

2.  Assessment of setup accuracy in patients receiving postmastectomy radiotherapy using electronic portal imaging.

Authors:  Funda Gul Koseoglu; Nina Tuncel; Adem Unal Kizildag; Melahat Garipagaoglu; Mustafa Adli; Cagatay Andic
Journal:  Radiat Med       Date:  2007-02-27

3.  Breast cancer and funnel chest. Comparing helical tomotherapy and three-dimensional conformal radiotherapy with regard to the shape of pectus excavatum.

Authors:  M Uhl; F Sterzing; G Habl; K Schubert; H Holger; J Debus; K Herfarth
Journal:  Strahlenther Onkol       Date:  2012-01-06       Impact factor: 3.621

4.  Cardiac motion during deep-inspiration breath-hold: implications for breast cancer radiotherapy.

Authors:  Xiaochun Wang; Tinsu Pan; Chelsea Pinnix; Sean X Zhang; Mohammad Salehpour; Tzouh Liang Sun; Gregory Gladish; Eric A Strom; George H Perkins; Welela Tereffe; Wendy Woodward; Karen E Hoffman; Thomas A Buchholz; T Kuan Yu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-03-26       Impact factor: 7.038

5.  Respiratory motion of the heart and positional reproducibility under active breathing control.

Authors:  Reshma Jagsi; Jean M Moran; Marc L Kessler; Robin B Marsh; James M Balter; Lori J Pierce
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-05-01       Impact factor: 7.038

6.  Comparison of dose distributions and organs at risk (OAR) doses in conventional tangential technique (CTT) and IMRT plans with different numbers of beam in left-sided breast cancer.

Authors:  Hande Bas Ayata; Metin Güden; Cemile Ceylan; Nadir Kücük; Kayihan Engin
Journal:  Rep Pract Oncol Radiother       Date:  2011-04-08

7.  Evaluation of skin dose associated with different frequencies of bolus applications in post-mastectomy three-dimensional conformal radiotherapy.

Authors:  Fundagul Andic; Yasemin Ors; Rima Davutoglu; Sule Baz Cifci; Emine Burcin Ispir; Mehmet Ertugrul Erturk
Journal:  J Exp Clin Cancer Res       Date:  2009-03-24

8.  Dosimetric comparison of helical tomotherapy and conventional Linac-based X-knife stereotactic body radiation therapy for primary lung cancer or pulmonary metastases.

Authors:  Shuangshuang Li; Ju Yang; Juan Liu; Shanbao Gao; Baorui Liu; Jing Yan
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

Review 9.  Cardiotoxicity of Radiation Therapy: Mechanisms, Management, and Mitigation.

Authors:  P Ell; J M Martin; D A Cehic; D T M Ngo; A L Sverdlov
Journal:  Curr Treat Options Oncol       Date:  2021-06-10

10.  Dosimetric comparison of intensity modulated radiotherapy isocentric field plans and field in field (FIF) forward plans in the treatment of breast cancer.

Authors:  Zakiya Salem Al-Rahbi; Zahid Al Mandhari; Ramamoorthy Ravichandran; Fatma Al-Kindi; Cheriyathmanjiyil Anthony Davis; Saju Bhasi; Namrata Satyapal; Balakrishnan Rajan
Journal:  J Med Phys       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.